Synergistic effects of bisphosphonate and calcium phosphate nanoparticles on peri-implant bone responses in osteoporotic rats

Biomaterials

Volumn 35, Issue 21, 2014, Pages 5482-5490

  Alghamdi, Hamdan S ^a,b   Bosco, Ruggero ^a   Both, Sanne K ^a   Iafisco, Michele ^c   Leeuwenburgh, Sander C G ^a   Jansen, John A ^a   Van den Beucken, Jeroen J J P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c INSTITUTE OF SCIENCE AND TECHNOLOGY FOR CERAMICS   (Italy)

Author keywords

Bisphosphonate; Bone healing; Calcium phosphate; Implants; Osteoporosis

Indexed keywords

CALCIUM PHOSPHATE; COATINGS; DENTAL PROSTHESES; DEPOSITION; DISEASES; GENE EXPRESSION; NANOPARTICLES; POLYMERASE CHAIN REACTION;

BISPHOSPHONATES; BONE HEALING; CALCIUM PHOSPHATE NANOPARTICLES; GENE EXPRESSION LEVELS; IMPLANTATION MODELS; OSTEOGENIC CAPACITY; OSTEOPOROSIS; SYNERGISTIC EFFECT;

BONE;

BIOMATERIAL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM PHOSPHATE; NANOPARTICLE; TITANIUM;

ANIMAL; BONE; BONE DEVELOPMENT; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; DRUG POTENTIATION; DRUG THERAPY; MALE; METABOLISM; OSTEOLYSIS; OSTEOPOROSIS; PROSTHESES AND ORTHOSES; RAT; SURFACE PROPERTY; WISTAR RAT;

ANIMALS; BONE AND BONES; BONE RESORPTION; CALCIUM PHOSPHATES; COATED MATERIALS, BIOCOMPATIBLE; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; MALE; NANOPARTICLES; OSTEOGENESIS; OSTEOPOROSIS; PROSTHESES AND IMPLANTS; RATS; RATS, WISTAR; SURFACE PROPERTIES; TITANIUM;

EID: 84899484537     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.03.069     Document Type: Article

References (43)

1. Learmonth I.D., Young C., Rorabeck C. The operation of the century: total hip replacement. Lancet 2007, 370:1508-1519.
2. Klibanski A., Adams-Campbell L., Bassford T., Blair S., Boden S., Dickersin K., et al. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285:785-795.
3. Kuehn B.M. Better osteoporosis management a priority. JAMA 2005, 293:2453-2458.
4. Chesnut C.H. Osteoporosis, an underdiagnosed disease. JAMA 2001, 286:2865-2866.
5. Bone H.G., Hosking D., Devogelaer J.P., Tucci J.R., Emkey R.D., Tonino R.P., et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women. NEngl J Med 2004, 350:1189-1199.
6. Downey P.A., Siegel M.I. Bone biology and the clinical implications for osteoporosis. Phys Ther 2006, 86:77-91.
7. Marco F., Milena F., Gianluca G., Vittoria O. Peri-implant osteogenesis in health and osteoporosis. Micron 2005, 36:630-644.
8. Puleo D., Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 1999, 20:2311-2321.
9. Kieswetter K., Schwartz Z., Dean D.D., Boyan B.D. The role of implant surface characteristics in the healing of bone. Crit Rev Oral Biol Med 1996, 7:329-345.
10. Browne M., Gregson P. Surface modification of titanium alloy implants. Biomaterials 1994, 15:894-898.
11. Mendonça G., Mendonça D., Aragão F., Cooper L. Advancing dental iplant surface technology - from micron - to nanotopography. Biomaterials 2008, 29:3822-3835.
12. Junker R., Dimakis A., Thoneick M., Jansen J.A. Effects of implant surface coatings and composition on bone integration: a systematic review. Clin Oral Implants Res 2009, 20(Suppl.4):185-206.
13. Bosco R., Edreira E.R.U., Wolke J.G., Leeuwenburgh S.C., van den Beucken J.J., Jansen J.A. Instructive coatings for biological guidance of bone implants. Surf Coat Technol 2013, 25:91-98.
14. Anselme K. Osteoblast adhesion on biomaterials. Biomaterials 2000, 21:667-681.
15. Leeuwenburgh S.C., Wolke J.G., Lommen L., Pooters T., Schoonman J., Jansen J.A. Mechanical properties of porous, electrosprayed calcium phosphate coatings. JBiomed Mater Res A 2006, 78:558-569.
16. de Jonge L.T., Leeuwenburgh S.C.G., Wolke J.G.C., Jansen J.A. Organic-inorganic surface modifications for titanium implant surfaces. Pharm Res 2008, 25:2357-2369.
17. Cattalini J.P., Boccaccini A.R., Lucangioli S., Mourino V. Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants. Tissue Eng Part B Rev 2012, 18:323-340.
18. Ginebra M., Traykova T., Planell J. Calcium phosphate cements as bone drug delivery systems: a review. JControl Release 2006, 113:102-110.
19. Peter B., Gauthier O., Laïb S., Bujoli B., Guicheux J., Janvier P., et al. Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats. JBiomed Mater Res A 2006, 76:133-143.
20. Alghamdi H.S., Bosco R., van den Beucken J.J., Walboomers X.F., Jansen J.A. Osteogenicity of titanium implants coated with calcium phosphate or collagen type-I in osteoporotic rats. Biomaterials 2013, 34:3747-3757.
21. Alghamdi H.S., van den Beucken J.J., Jansen J.A. Osteoporotic rat models for evaluation of osseointegration of bone implants. Tissue Eng Part C Methods 2013 Nov 26, [Epub ahead of print] PMID: 24124802.
22. de Jonge L.T., Leeuwenburgh S.C., van den Beucken J.J., te Riet J., Daamen W.F., Wolke J.G., et al. The osteogenic effect of electrosprayed nanoscale collagen/calcium phosphate coatings on titanium. Biomaterials 2010, 31:2461-2469.
23. Iafisco M., Bosco R., Leeuwenburgh S.C.G., van den Beucken J.J.J.P., Jansen J.A., Prat M., et al. Electrostatic spray deposition of biomimetic nanocrystalline apatite coatings onto titanium. Adv Eng Mater 2012, 14:B13-B20.
24. van den Dolder J., Bancroft G.N., Sikavitsas V.I., Spauwen P.H., Jansen J.A., Mikos A.G. Flow perfusion culture of marrow stromal osteoblasts in titanium fiber mesh. JBiomed Mater Res A 2003, 64:235-241.
25. Iafisco M., Palazzo B., Falini G., Foggia M.D., Bonora S., Nicolis S., et al. Adsorption and conformational change of myoglobin on biomimetic hydroxyapatite nanocrystals functionalized with alendronate. Langmuir 2008, 24:4924-4930.
26. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108.
27. Puelo D., Nanci A. Understanding and controlling the bone implant interface. Biomaterials 1999, 20:2311-2321.
28. Chai Y.C., Carlier A., Bolander J., Roberts S.J., Geris L., Schrooten J., et al. Current views on calcium phosphate osteogenicity and the translation into effective bone regeneration strategies. Acta Biomater 2012, 8:3876-3887.
29. de Jonge L.T., van den Beucken J.J., Leeuwenburgh S.C., Hamers A.A., Wolke J.G., Jansen J.A. Invitro responses to electrosprayed alkaline phosphatase/calcium phosphate composite coatings. Acta Biomater 2009, 5:2773-2782.
30. Yoshinari M., Oda Y., Inoue T., Matsuzaka K., Shimono M. Bone response to calcium phosphate-coated and bisphosphonate-immobilized titanium implants. Biomaterials 2002, 23:2879-2885.
31. Yoshinari M., Oda Y., Ueki H., Yokose S. Immobilization of bisphosphonates on surface modified titanium. Biomaterials 2001, 22:709-715.
32. Wermelin K., Suska F., Tengvall P., Thomsen P., Aspenberg P. Stainless steel screws coated with bisphosphonates gave stronger fixation and more surrounding bone. Histomorphometry in rats. Bone 2008, 42:365-371.
33. Peter B., Pioletti D.P., Laib S., Bujoli B., Pilet P., Janvier P., et al. Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration. Bone 2005, 36:52-60.
34. Bobyn J.D., McKenzie K., Karabasz D., Krygier J.J., Tanzer M. Locally delivered bisphosphonate for enhancement of bone formation and implant fixation. JBone Joint Surg Am 2009, 91(Suppl.6):23-31.
35. Nakamura Y., Hayashi K., Abu-Ali S., Naito M., Fotovati A. Effect of preoperative combined treatment with alendronate and calcitriol on fixation of hydroxyapatite-coated implants in ovariectomized rats. JBone Joint Surg Am 2008, 90:824-832.
36. Rodan G.A. Mechanisms of action of bisphosphonates. Annu Rev Pharmacol Toxicol 1998, 38:375-388.
37. Barradas A., Fernandes H.A.M., Groen N., Chai Y.C., Schrooten J., van de Peppel J., et al. Acalcium-induced signaling cascade leading to osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells. Biomaterials 2012, 33:3205-3215.
38. Clapham D.E. Calcium signaling. Cell. 2007, 131:1047-1058.
39. Kokubo T., Takadama H. How useful is SBF in predicting invivo bone bioactivity?. Biomaterials 2006, 27:2907-2915.
40. Rogers M.J., Crockett J.C., Coxon F.P., Monkkonen J. Biochemical and molecular mechanisms of action of bisphosphonates. Bone 2011, 49:34-41.
41. Plotkin L.I., Weinstein R.S., Parfitt A.M., Roberson P.K., Manolagas S.C., Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. JClin Invest 1999, 104:1363-1374.
42. Jimbo R., Xue Y., Hayashi M., Schwartz-Filho H.O., Andersson M., Mustafa K., et al. Genetic responses to nanostructured calcium-phosphate-coated implants. JDent Res 2011, 90:1422-1427.
43. Mendonça G., Mendonça D., Simões L.G., Araújo A.L., Leite E.R., Duarte W.R., et al. The effects of implant surface nanoscale features on osteoblast-specific gene expression. Biomaterials 2009, 30:4053-4062.